[1]
A. A. AL-SHOUBKI, M. H. TEAIMA, R. ABDELMONEM, M. A. EL-NABARAWI, and S. F. ELHABAL, “BIOAVAILABILITY ENHANCEMENT STRATEGIES FOR RIVAROXABAN: A NOTEWORTHY REVIEW”, Int J App Pharm, vol. 15, no. 6, pp. 33–37, Nov. 2023.